ASCO 2024 Highlights

ASCO Michigan 2024 | Highlights from ASCO in Non-Small Cell Lung CancerПодробнее

Key Takeaways From the 2024 ASCO Quality Care SymposiumПодробнее

Key Takeaways From the 2024 ASCO Quality Care SymposiumПодробнее

Yale Advancements in Oncology: Implementing the Best Science from ASCO® 2024 and BeyondПодробнее

Oncogene-addicted NSCLC update from WCLC and ESMO 2024Подробнее

Dr. Junaid Arshad: Tadalafil & New Approaches to Gastric Cancer | ASCO 2024Подробнее

ASCO 2024: Updates on Clinical Trials in Gynecologic CancersПодробнее

Key Multiple Myeloma Abstracts Presented at 2024 ASCO and EHA MeetingПодробнее

Highlights from ASCO 2024Подробнее

Key melanoma highlights from ASCO 2024, including RELATIVITY-048 and NADINA trialsПодробнее

Advancements in prostate cancer therapies from ASCO 2024Подробнее

Key takeaways from ASCO 2024: advances in kidney cancer biomarkers and neoadjuvant therapyПодробнее

Highlights in lung cancer from ASCO 2024Подробнее

Best of ASCO 2024 - 07/16/24 - Lung Cancer Living Room™Подробнее

What’s New In Diffuse Large B-Cell LymphomaUpdates from ASCO 2024 & the EHA Hybrid CongressПодробнее

Prostate Cancer Research Updates: ASCO 2024 | ZERO Prostate CancerПодробнее

Amazing Results! President Lynn Schuchter on ASCO 2024Подробнее

Latest Advances in Breast Cancer Care: Highlights From Chicago 2024Подробнее

Gustave Roussy à l'ASCO 2024 - Tumeurs ORL / Tumeurs cérébralesПодробнее